v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (15,618,383) $ (4,396,629)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 18,784 10,577
Amortization expense 1,495,659 569,932
Finance fee 1,745,985 422,078
Change in allowance for doubtful accounts 123,797 110,520
Stock compensation expense 5,785,528 1,024,144
Non-cash interest expense 626,572 103,539
Change in fair value of forward purchase agreement 2,162,673 0
Gain on sale of assets   13,778
Changes in operating assets and liabilities:    
Accounts receivable (208,425) (61,651)
Prepaid expenses and other current assets 1,232,782 (203,949)
Right of use asset, net of lease liability 2,063 3,961
Accounts payable and accrued expenses 1,595,770 409,777
Deferred revenue 28,710 74,293
NET CASH USED IN OPERATING ACTIVITIES (1,008,485) (1,919,630)
INVESTING ACTIVITIES    
Cash portion of consideration paid to acquire assets - Verifi Dental Limited (370,000) 0
Cash portion of consideration paid to acquire assets - FeatherPay (500,000) 0
Sale of capital assets 0 28,000
Purchase of capital assets 0 (178,150)
Additions to capitalized software (465,837) (359,758)
NET CASH USED IN INVESTING ACTIVITIES (1,335,837) (509,908)
FINANCING ACTIVITES    
Net proceeds from debt 2,812,001 2,263,010
Payments on debt (1,439,843) (1,186,223)
Proceeds from issuance of common stock 0 540,000
Stock issued for conversion of convertible debt 0 685,333
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,372,158 2,302,120
NET CHANGE IN CASH (972,164) (127,418)
CASH AT BEGINNING OF THE PERIOD 1,219,358 196,153
CASH AT END OF THE PERIOD 247,194 68,735
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid during the period for interest 132,566 348,941
Stock issued for acquisitions $ 62 $ 0

Source